OptiVivax (@OptiVivax) / X

OptiVivax

20 posts

OptiVivax

@OptiVivax

OptiViVax, A New International Collaboration to Optimise a Vaccine for Plasmodium Vivax Malaria.

Oxford

Joined October 2023

OptiVivax
@OptiVivax
Jan 28, 2025
Great podcast by Andrew Duncan explaining our latest P. vivax malaria challenge clinical trial. Part of the #OptiVivax Consortium working with the @OxfordVacGroup and @KavliOxford ovg.ox.ac.uk/studies/bio006 @OxPaediatrics @OxfordMedSci @UniofOxford @KavliFoundation
ovg.ox.ac.uk
BIO-006
OptiVivax
@OptiVivax
Jan 23, 2025
#OptiViVax launches a first-in-kind clinical trial, BIO-006, with the @OxfordVacGroup to investigate relapsing malaria infection caused by Plasmodium vivax. Find out more here: optivivax.web.ox.ac.uk/article/draper… @KavliOxford @OxfordMedSci @UniofOxford @KavliFoundation @OxPaediatrics
optivivax.site.ox.ac.uk
OptiViVax Launches a First-in-kind Clinical Trial on Relapsing Malaria
OptiVivax
@OptiVivax
May 7, 2024
Plasmodium vivax is the most widespread human malaria with 2.5 billion people living at risk in South America, Oceania and Asia. In this study, researchers tested a range of conditions to evaluate growth inhibition assays for Plasmodium vivax.
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax...
From pubmed.ncbi.nlm.nih.gov
OptiVivax
@OptiVivax
Apr 25, 2024
Clinical trials are critical to the development of malaria vaccines, please consider applying. #WorldMalariaDay #clinicaltrials
OptiVivax
@OptiVivax
Apr 25, 2024
Clinical trials are critical to the development of malaria vaccines, please consider applying. #WorldMalariaDay #clinicaltrials lnkd.in/eD7RNiJ7